eMedevents
  • 151,131+ Medical Conferences
  • 284 Specialties
  • 11,120 Organizers
  • 155,414 Speakers
  • 159 Countries
  • 4,738 Cities
50,377+
CME Conference Registrations Sold
Home  >  Speakers  >  Amnon Peled
Amnon Peled

Amnon Peled

    M.Sc, Ph.D
Professor | Jerusalem, Jerusalem    Israel
Genetics, Practice Management
The CXCR4 Antagonist BL-8040 Synergizes With The Gene Therapy,...More
Spoken at 1 event

Biography :

Prof. Amnon Peled is the founder and Chief Scientific Officer of Biokine Therapeutics Ltd. Prof. Peled is a world-renowned expert in chemokine research, specifically on the CXCR4 receptor. He has published over 80 peer-reviewed papers in prestigious journals, such as Blood, JCI and Science. Prof. Peled is currently a Professor at the Gene Therapy Institute, Hadassah Medical Center, Jerusalem where he directs a laboratory focusing on the role of chemokines and chemokine receptors for the treatment of cancer and immune diseases. Professor Peled’s work experience includes Millennium Pharmaceuticals Inc., where he was the head of a group studying CXCR4 function in allergy. Prof. Peled has a Ph.D. from the Department of Cell Biology at the Weizmann Institute of Science.

*********************
**********
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Genetics, Practice Management

Interested Topics

The CXCR4 Antagonist BL-8040 Synergizes with the FLT3 Inhibitor AC220 to Induce Apoptosis and Reduce Minimal Residual Disease of AML Cells In Vivo, Gene therapy, Genetics, Treatment of cancer, Immune disease, Cell Biology, Chemokines, Chemokine receptors, Tumor metastasis, Inflammation, Natural killer cells

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English, Hebrew
Close

Send Message